KIDS WELL, ALL WELL
For the Future
New Biologics Business
New biotech business (cell therapy)
Hybrid Structure for Business Operations
Virtual business structure and Project management
Establishment of Cell Therapy Platform
IR Policy / Disclaimer
Major financial indicators over the past five years
(Scroll horizontally by tapping)
Note:The Company conducted a 2-for-1 stock split on October 1, 2016.
Above per share indicators have been calculated as if this stock split had taken place at the beginning of FY3/2015.